Recent Finacing
Recent Raise
Hengrui Therapeutics is a Princeton-based biopharmaceutical company developing and commercializing multiple clinical-stage oncology and immuno-oncology therapeutics, building U.S. and global clinical development and commercialization infrastructure.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor